Association between blood glucose level derived using the oral glucose tolerance test and glycated hemoglobin level |
Kim, Hyoung Joo
(Department of Internal Medicine, Ajou University School of Medicine)
Kim, Young Geon (Department of Internal Medicine, Ajou University School of Medicine) Park, Jin Soo (Department of Internal Medicine, Ajou University School of Medicine) Ahn, Young Hwan (Department of Internal Medicine, Ajou University School of Medicine) Ha, Kyoung Hwa (Department of Endocrinology and Metabolism, Ajou University School of Medicine) Kim, Dae Jung (Department of Endocrinology and Metabolism, Ajou University School of Medicine) |
1 | Jeon JY, Kim DJ, Ko SH, et al. Current status of glycemic control of patients with diabetes in Korea: the fifth Korea national health and nutrition examination survey. Diabetes Metab J 2014;38:197-203. DOI |
2 | Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992;15:815-819. DOI |
3 | International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334. DOI |
4 | American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 Suppl 1:S62-S69. DOI |
5 | Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008;93:2447-2453. DOI |
6 | Beard E, Clark M, Hurel S, Cooke D. Do people with diabetes understand their clinical marker of long-term glycemic control (HbA1c levels) and does this predict diabetes self-care behaviours and HbA1c? Patient Educ Couns 2010;80:227-232. DOI |
7 | Nathan DM, Kuenen J, Borg R, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-1478. DOI |
8 | Makris K, Spanou L. Is there a relationship between mean blood glucose and glycated hemoglobin? J Diabetes Sci Technol 2011;5:1572-1583. DOI |
9 | Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-412. DOI |
10 | The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986. DOI |
11 | Control Group, Turnbull FM, Abraira C, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009;52:2288-2298. DOI |
12 | American Diabetes Association. Postprandial blood glucose. Diabetes Care 2001;24:775-778. DOI |
13 | Del Prato S. Loss of early insulin secretion leads to postprandial hyperglycaemia. Diabetologia 2003;46 Suppl 1:M2-M8. DOI |
14 | Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 2003;26:881-885. DOI |
15 | Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 2002;25:275-278. DOI |
16 | Goldstein DE, Little RR, Lorenz RA, et al. Tests of glycemia in diabetes. Diabetes Care 2004;27:1761-1773. DOI |
17 | Yoon KH, Ko SH, Cho JH, et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003;88:2300-2308. DOI |